Simon Quick Advisors’s Sage Therapeutics SAGE Stock Holding History

Simon Quick Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2	Closed	-$366	–	495
2019 Q2	$366	Buy	+2	New	+$341	﹤0.01%	462

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Simon Quick Advisors's SAGE Position: Q3 2019 in Review

Simon Quick Advisors sold out of Sage Therapeutics (SAGE) in Q3 2019, closing a stake of 2 shares — an estimated $366 sold.

Simon Quick Advisors first reported a position in SAGE in Q2 2019 and held it in 1 quarter. The position peaked at $366 in Q2 2019. 284 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

Simon Quick Advisors reported no remaining Sage Therapeutics position as of Q3 2019 after selling out during the quarter.
Simon Quick Advisors sold 2 Sage Therapeutics shares in Q3 2019, an estimated $366.
Simon Quick Advisors first reported a position in Sage Therapeutics in Q2 2019 and held it in 1 quarter.
Simon Quick Advisors's Sage Therapeutics position peaked at $366 in Q2 2019.
284 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on Simon Quick Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.